TrialLeukemia & lymphoma2021
Safety and efficacy of navitoclax, a BCL-2 and BCL-X
Sven de Vos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
66 papers cite itlatest 60 shown
this papercites it
TrialLeukemia & lymphoma2021
Sven de Vos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.